41 reports

  • Germany

It has been predicted that the rate of cancer is expected to increase by about ##% by 2020, which will lead to the discovery of potential drugs to treat cancer.

  • Cholesterol
  • World
  • Forecast
  • Archer Daniels Midland Company
  • Cargill Inc.

Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/ Chart) Table ##: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Mala

  • Cholesterol
  • Chronic Disease
  • Europe
  • United States
  • World

Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/ Chart) Table ##: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB &

  • Cholesterol
  • Europe
  • Japan
  • United States
  • World

Discovers and develops HDL therapies indicated to treat cardiovascular and metabolic diseases Develops drugs for the treatment of digestive or inflammatory diseases and cancers A research-based pharmaceutical company that undertakes the development, manufacture, and marketing of pharmaceuti

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC

Cancer Mortality for Selected Sites in ## Countries (1950-##).

  • Cholesterol
  • China
  • Germany
  • Japan
  • Forecast

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

cancer Key Highlights ##. ##. ## Key Developments Company Details Description ##. ##. ## SWOT Analysis ##. ## MERCK ##. ##. ## Key Facts Stock Listings Ticker Symbol Company Details Description New York Stock Exchange MRK ##. ##. ## Business Overview Merck & Co.

  • Cholesterol
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • SIZE OF THE MARKET

Cancer Urine Strip Miscellaneous The professional sector is made up of tests used in hospitals, physician offices and clinics.

  • Cholesterol
  • Point Of Care Testing
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

In relation to cancer risk, the EAS guidelines draw on evidence from animal and cell studies to suggest a protective role of sitosterol against certain cancers, and thus to dismiss cancer risk with recommended daily intakes of functional foods containing ##-##g/ day of p

  • Cholesterol
  • Europe
  • Danone SA
  • Raisio Group
  • Unilever PLC

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

CANCER MORTALITY FOR SELECTED SITES IN ## COUNTRIES (1950-##).

  • Cholesterol
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

The company offers its product portfolio in the therapeutic areas of breast cancer, colorectal cancer and lung cancer.

  • Cholesterol
  • Clinical Trial
  • Infectious Disease
  • United States
  • GlobalData's company
  • AF-122 - Drug Profile

The company' s products include proprietary molecules, natural new chemical entities, biomarkers, metabolite, and anti cancer drugs.

  • Antimalarials
  • Cholesterol
  • United States
  • Product Initiative
  • Vitae Pharmaceuticals, Inc.
  • BEXAROTENE - DRUG PROFILE

APR ##, 2013: ADDF AND BRIGHTFOCUS FOUNDATION COLLABORATE TO FUND PHASE I STUDY OF CANCER DRUG BEXAROTENE IN ALZHEIMER' S DISEASE PATIENTS The Alzheimer' s Drug Discovery Foundation (ADDF) and BrightFocus Foundation announced a funding collaboration that will support a Phase I human

  • Cardiovascular Disease
  • Cholesterol
  • United States
  • Product Initiative
  • LipimetiX Development LLC

It also develops JX##, a chemosensitizing oncolytic immunotherapy that eradicates cancer; activates chemotherapy in cancer tissue; administers as a monotherapy to patients with breast, colorectal, and pancreatic cancer; and treats melanoma and metastatic colon

  • Cholesterol
  • Therapy
  • United States
  • Company Financials
  • Regeneron Pharmaceuticals, Inc.
  • AMGEN INC
  • DYSLIPIDEMIA - PIPELINE BY ASTRAZENECA PLC, H1 2017

THE DRUG CANDIDATE IS IN PHASE II STAGE OF DEVELOPMENT FOR NON SMALL CELL LUNG CANCER (THIRD LINE THERAPY), PANCREATIC CANCER, COLORECTAL CANCER, NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA.

  • Cholesterol
  • Obesity
  • Pharmaceutical
  • Statins
  • Esperion Therapeutics, Inc.
  • Pipeline by Amgen Inc., H1 2016

It provides prescription medicines for the treatment of diabetes, hemophilia, harmone dificiency, high blood pressure, ulcers, skin ailments, cancer, allergy, and others.

  • Cholesterol
  • South Korea
  • United States
  • World
  • Product Initiative

The company develops tumor activated prosoft drugs for cancer.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis

Alvogen develops medicines for senile diseases such as cancer, high blood pressure, diabetes, stroke, heart disease, Alzheimer' s, metabolic diseases, and others.

  • Cholesterol
  • South Korea
  • United States
  • World
  • Product Initiative
  • APOLIPOPROTEIN A-I (APOA-I) - COMPANIES INVOLVED IN THERAPEUTICS DEVELOPMENT

The company develops tumor activated prosoft drugs for cancer.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis

Alvogen develops medicines for senile diseases such as cancer, high blood pressure, diabetes, stroke, heart disease, Alzheimers, metabolic diseases, and others.

  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • Pipeline by Amgen Inc., H1 2016
  • Pipeline by Merck & Co., Inc., H1 2016

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Cardiovascular Disease
  • Cholesterol
  • United States
  • World
  • Product Initiative
  • 8.2.1 U.S.
  • U.S.: CHOLESTEROL TESTING SERVICES MARKET SIZE, BY TYPE OF CUSTOMER, 2014-2021 (USD MILLION)

This demographic shift is expected to bring more attention on preventing the occurrence of diseases associated with this age group, including cancer, stroke, diabetes, and CVD.

  • Cholesterol
  • United States
  • Forecast
  • Market Size
  • OPKO Health, Inc.
  • DYSLIPIDEMIA - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2017
  • DYSLIPIDEMIA - PIPELINE BY GOLDEN BIOTECHNOLOGY CORP, H2 2017

Its pipeline products are used in the treatment of stomach cancer, lung cancer, eating disorder, angina, hair loss and musculoskeletal system disorder.

  • Cholesterol
  • Chronic Disease
  • United States
  • World
  • Product Initiative

Cleveland Clinic' s network of facilities includes regional hospitals; regional care centers; a children' s hospital; a research labs and facilities for pathology and cancer, eye, heart and urologic care.

  • Cholesterol
  • Lipid Modifying Drug
  • Therapy
  • United States
  • Esperion Therapeutics, Inc.

It acts on the functional site of the cancer-causing protein.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Kowa Co., Ltd.
  • O-304 - DRUG PROFILE
  • ND-630 - DRUG PROFILE

The cell lines used originated from different types of cancer: meningiomas, leukemia, lung cancer, gastrointestinal tumors, pancreatic cancer, myeloproliferative disorders, skin cancer (dermatofibrosarcoma), colon cancer, breast cancer, thyroid

  • Cholesterol
  • Digestive System Disorder
  • Pharmaceutical
  • United States
  • Product Initiative